Literature DB >> 10699267

Targeted drug delivery for brain cancer treatment.

R L Gutman1, G Peacock, D R Lu.   

Abstract

The blood brain barrier (BBB) and the systemic toxicity of conventional chemotherapy present obstacles to the success of future blood-borne drug therapies of brain tumors. The work with polymer-encapsulated cancer drugs suggests an alternative and more focused treatment approach. Our experimental strategy integrates direct intracerebral drug delivery, sustained drug release from liposomes or polymer implants, and increased targeting of the drug either by chemically modifying the drug or by using tumor-specific carriers. This review will present some of the recent work on targeted drug delivery for brain cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10699267     DOI: 10.1016/s0168-3659(99)00229-1

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  12 in total

Review 1.  Planning for intracavitary anti-EGFR radionuclide therapy of gliomas. Literature review and data on EGFR expression.

Authors:  J Carlsson; Z P Ren; K Wester; A L Sundberg; N E Heldin; G Hesselager; M Persson; L Gedda; V Tolmachev; H Lundqvist; E Blomquist; M Nistér
Journal:  J Neurooncol       Date:  2006-03       Impact factor: 4.130

2.  Apoptosis-induced anticancer effect of transferrin-conjugated solid lipid nanoparticles of curcumin.

Authors:  Rohit S Mulik; Jukka Mönkkönen; Risto O Juvonen; Kakasaheb R Mahadik; Anant R Paradkar
Journal:  Cancer Nanotechnol       Date:  2012-11-13

3.  Multifunctional biodegradable polyacrylamide nanocarriers for cancer theranostics--a "see and treat" strategy.

Authors:  Shouyan Wang; Gwangseong Kim; Yong-Eun Koo Lee; Hoe Jin Hah; Manivannan Ethirajan; Ravindra K Pandey; Raoul Kopelman
Journal:  ACS Nano       Date:  2012-07-06       Impact factor: 15.881

4.  Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration.

Authors:  Beata Chertok; Allan E David; Victor C Yang
Journal:  Biomaterials       Date:  2010-05-21       Impact factor: 12.479

Review 5.  Magnetic nanoparticles for tumor imaging and therapy: a so-called theranostic system.

Authors:  Huining He; Allan David; Beata Chertok; Adam Cole; Kyuri Lee; Jian Zhang; Jianxin Wang; Yongzhuo Huang; Victor C Yang
Journal:  Pharm Res       Date:  2013-01-24       Impact factor: 4.200

6.  Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors.

Authors:  Beata Chertok; Bradford A Moffat; Allan E David; Faquan Yu; Christian Bergemann; Brian D Ross; Victor C Yang
Journal:  Biomaterials       Date:  2007-10-26       Impact factor: 12.479

Review 7.  Adenosine-associated delivery systems.

Authors:  Mehdi Kazemzadeh-Narbat; Nasim Annabi; Ali Tamayol; Rahmi Oklu; Amyl Ghanem; Ali Khademhosseini
Journal:  J Drug Target       Date:  2015       Impact factor: 5.121

8.  Uptake of the carborane derivative of cholesteryl ester by glioma cancer cells is mediated through LDL receptors.

Authors:  Guangliang Pan; Svein Oie; D Robert Lu
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

9.  Nanoparticulate radiolabelled quinolines detect amyloid plaques in mouse models of Alzheimer's disease.

Authors:  Celeste A Roney; Veera Arora; Padmakar V Kulkarni; Peter P Antich; Frederick J Bonte
Journal:  Int J Alzheimers Dis       Date:  2010-01-27

10.  Peptide-mediated targeting of liposomes to TrkB receptor-expressing cells.

Authors:  Sanjeev Ranjan; Rohit Sood; Jozsef Dudas; Rudolf Glueckert; Anneliese Schrott-Fischer; Soumen Roy; Ilmari Pyykkö; Paavo K J Kinnunen
Journal:  Int J Nanomedicine       Date:  2012-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.